Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
10,127,392
-
Share change
-
-4,358,069
-
Total reported value
-
$12,249,000
-
Put/Call ratio
-
34%
-
Price per share
-
$1.21
-
Number of holders
-
50
-
Value change
-
-$30,132,718
-
Number of buys
-
22
-
Number of sells
-
34
Institutional Holders of REPROS THERAPEUTICS INC - COM NEW (RPRX) as of Q4 2015
As of 31 Dec 2015,
REPROS THERAPEUTICS INC - COM NEW (RPRX) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,127,392 shares.
The largest 10 holders included
FMR LLC, Sarissa Capital Management LP, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, BlackRock Institutional Trust Company, N.A., GENERAL AMERICAN INVESTORS CO INC, Allegis Investment Advisors, LLC, Gruss Capital Management LP, D. E. Shaw & Co., Inc., and A.R.T. Advisors, LLC.
This page lists
50
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.